May 9, 2023
Upon Japan’s severity downgrade of COVID-19, the Japan Pharmaceutical Manufacturers Association (JPMA) issued a statement on May 8 underlining the need for special government support to help the industry sustain its infectious disease business beyond the pandemic. In the statement,...read more